273 related articles for article (PubMed ID: 31863793)
1. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
Theerawatanasirikul S; Kuo CJ; Phetcharat N; Lekcharoensuk P
Antiviral Res; 2020 Feb; 174():104697. PubMed ID: 31863793
[TBL] [Abstract][Full Text] [Related]
2. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.
Kim Y; Mandadapu SR; Groutas WC; Chang KO
Antiviral Res; 2013 Feb; 97(2):161-8. PubMed ID: 23219425
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
5. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
Jiao Z; Yan Y; Chen Y; Wang G; Wang X; Li L; Yang M; Hu X; Guo Y; Shi Y; Peng G
J Virol; 2022 Sep; 96(17):e0090722. PubMed ID: 36000844
[TBL] [Abstract][Full Text] [Related]
6. X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design.
St John SE; Therkelsen MD; Nyalapatla PR; Osswald HL; Ghosh AK; Mesecar AD
Bioorg Med Chem Lett; 2015 Nov; 25(22):5072-7. PubMed ID: 26592814
[TBL] [Abstract][Full Text] [Related]
7. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
Kim Y; Liu H; Galasiti Kankanamalage AC; Weerasekara S; Hua DH; Groutas WC; Chang KO; Pedersen NC
PLoS Pathog; 2016 Mar; 12(3):e1005531. PubMed ID: 27027316
[TBL] [Abstract][Full Text] [Related]
8. An RNA replicon system to investigate promising inhibitors of feline coronavirus.
Schmied K; Ehmann R; Kristen-Burmann C; Ebert N; Barut GT; Almeida L; Kelly JN; Thomann L; Stalder H; Lang R; Tekes G; Thiel V
J Virol; 2024 Feb; 98(2):e0121623. PubMed ID: 38236006
[TBL] [Abstract][Full Text] [Related]
9. Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.
McDonagh P; Sheehy PA; Norris JM
Vet Microbiol; 2015 Mar; 176(1-2):10-8. PubMed ID: 25596968
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterisation of small molecule inhibitors of feline coronavirus replication.
McDonagh P; Sheehy PA; Norris JM
Vet Microbiol; 2014 Dec; 174(3-4):438-447. PubMed ID: 25465182
[TBL] [Abstract][Full Text] [Related]
11. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
[TBL] [Abstract][Full Text] [Related]
12. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies.
Murphy BG; Perron M; Murakami E; Bauer K; Park Y; Eckstrand C; Liepnieks M; Pedersen NC
Vet Microbiol; 2018 Jun; 219():226-233. PubMed ID: 29778200
[TBL] [Abstract][Full Text] [Related]
13. Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor.
Perera KD; Rathnayake AD; Liu H; Pedersen NC; Groutas WC; Chang KO; Kim Y
Vet Microbiol; 2019 Oct; 237():108398. PubMed ID: 31585653
[TBL] [Abstract][Full Text] [Related]
14. Crystallization and preliminary crystallographic study of Feline infectious peritonitis virus main protease in complex with an inhibitor.
Wang J; Wang F; Tan Y; Chen X; Zhao Q; Fu S; Li S; Chen C; Yang H
Acta Crystallogr F Struct Biol Commun; 2014 Dec; 70(Pt 12):1612-5. PubMed ID: 25484209
[TBL] [Abstract][Full Text] [Related]
15. Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection.
Doki T; Takano T; Koyama Y; Hohdatsu T
Virus Res; 2015 Jun; 204():13-20. PubMed ID: 25896976
[TBL] [Abstract][Full Text] [Related]
16. Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene.
Chang HW; de Groot RJ; Egberink HF; Rottier PJ
J Gen Virol; 2010 Feb; 91(Pt 2):415-20. PubMed ID: 19889934
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
Takano T; Satoh K; Doki T; Tanabe T; Hohdatsu T
Viruses; 2020 May; 12(5):. PubMed ID: 32456286
[TBL] [Abstract][Full Text] [Related]
18. Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376.
Ye G; Wang X; Tong X; Shi Y; Fu ZF; Peng G
Viruses; 2020 Feb; 12(2):. PubMed ID: 32098094
[TBL] [Abstract][Full Text] [Related]
19. Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus.
Zhou M; Han Y; Li M; Ye G; Peng G
Virol Sin; 2021 Dec; 36(6):1421-1430. PubMed ID: 34228261
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the active centre of coronavirus 3C-like proteases.
Hegyi A; Friebe A; Gorbalenya AE; Ziebuhr J
J Gen Virol; 2002 Mar; 83(Pt 3):581-593. PubMed ID: 11842253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
